Literature DB >> 15638468

DOTAP (and other cationic lipids): chemistry, biophysics, and transfection.

Dmitri Simberg1, Sarah Weisman, Yeshayahu Talmon, Yechezkel Barenholz.   

Abstract

Cationic lipid-mediated nucleic acid and protein delivery is becoming increasingly popular for in vitro and in vivo applications. While the chemistry of cationic lipid carriers is moving very rapidly, and more and more sophisticated molecules are being developed, it is worthwhile to look back to understand what has been achieved in the field of cationic lipids and why in some cases delivery based on cationic lipids works and in other cases it does not. For this purpose, DOTAP is one of the best candidates; it is the most widely used cationic lipid, it is relatively cheap, and it is efficient in both in vitro and in vivo applications. The vast amount of data that have accumulated on DOTAP and related molecules could provide invaluable clues to biophysical, structural, and biological mechanisms of transfection by cationic lipids. While many issues of cationic lipid transfection still remain unclear, this review will attempt to address mainly the following issues: (1) interplay of physicochemical parameters of DOTAP formulations; (2) impact of physicochemical parameters on transfection (lipofection) efficiency by cationic reagents, in vitro and in vivo; (3) structure-activity relationships of cationic lipid formulations in cell culture and in the living organism. In addition, in vivo applications of cationic lipids are reviewed, and the problems of local versus systemic administration of lipoplexes are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638468     DOI: 10.1615/critrevtherdrugcarriersyst.v21.i4.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  49 in total

Review 1.  Cationic liposome/DNA complexes: from structure to interactions with cellular membranes.

Authors:  Giulio Caracciolo; Heinz Amenitsch
Journal:  Eur Biophys J       Date:  2012-06-19       Impact factor: 1.733

2.  A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Authors:  Carina L Buzzo; Julia C Campopiano; Liliana M Massis; Silvia L Lage; Alexandra A Cassado; Rafael Leme-Souza; Larissa D Cunha; Momtchilo Russo; Dario S Zamboni; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

3.  Lipid bilayer membrane-triggered presynaptic vesicle assembly.

Authors:  Gopakumar Gopalakrishnan; Peter Thostrup; Isabelle Rouiller; Anna Lisa Lucido; Wiam Belkaïd; David R Colman; R Bruce Lennox
Journal:  ACS Chem Neurosci       Date:  2009-10-15       Impact factor: 4.418

4.  Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications.

Authors:  Luc Wasungu; Marco Scarzello; Gooitzen van Dam; Grietje Molema; Anno Wagenaar; Jan B F N Engberts; Dick Hoekstra
Journal:  J Mol Med (Berl)       Date:  2006-06-08       Impact factor: 4.599

Review 5.  Liposome-nucleic acid immunotherapeutics.

Authors:  Steven Dow
Journal:  Expert Opin Drug Deliv       Date:  2008-01       Impact factor: 6.648

Review 6.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

7.  Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses.

Authors:  Silvia L Lage; Carina L Buzzo; Eduardo P Amaral; Kely C Matteucci; Liliana M Massis; Marcelo Y Icimoto; Adriana Karaoglanovic Carmona; Maria R D'Império Lima; Mauricio M Rodrigues; Luis C S Ferreira; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-13       Impact factor: 11.205

8.  Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis.

Authors:  Burhan Kabay; Cetin Kocaefe; Atac Baykal; Hilmi Ozden; Cengiz Baycu; Zafer Oner; Meral Ozgüç; Iskender Sayek
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

9.  In vitro evaluation of TLR4 agonist activity: formulation effects.

Authors:  Ayesha Misquith; H W Millie Fung; Quinton M Dowling; Jeffrey A Guderian; Thomas S Vedvick; Christopher B Fox
Journal:  Colloids Surf B Biointerfaces       Date:  2013-09-19       Impact factor: 5.268

Review 10.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.